The Ketamine Podcast
Dr. Steven Radowitz: Ketamine for Alcoholism. The KARE Protocol
April 16, 2023
Dr. Steven Radowitz, the Chief Medical Officer and Co-Founder of Nushama, is a strong advocate of psychedelic medicine as a tool for mental wellness. He oversees the development of treatment modalities that integrate neuroscience, mystical experience, and integration therapy. His team at Nushama offers Ketamine for the Reduction of Alcohol Relapse (KARE), a ketamine-assisted psychotherapy protocol that has been found to be 86% effective. He believes that psychedelic medicine is the future of mental wellness and preventive medicine. Dr. Radowitz has been practicing internal medicine and primary care since 1998, and he has mentored students attending the Columbia School of Social Work interning at Nushama for their field practicum.
Dr. Steven Radowitz, the Chief Medical Officer and Co-Founder of Nushama, has a wealth of experience seeing the effects of trauma and addiction on physical health. He started his career in New York during the peak of the opioid and AIDS crises, where he worked as the medical director of the inpatient alcohol and opiate detox and treatment unit at St. Vincent’s NYC Midtown medical center. With his team at Nushama, he supports people struggling with substance use by developing treatment modalities that integrate neuroscience, mystical experience, and integration therapy. He believes that current solutions often fall short, treating symptoms without addressing underlying issues, and that psychedelic medicine's framework is the future of mental wellness.

Dr. Radowitz's team offers Ketamine for the Reduction of Alcohol Relapse (KARE), a highly efficacious ketamine-assisted psychotherapy protocol that has been found to be 86% effective. Nushama is the first to bring this revolutionary treatment to New York City, using the power of psychedelics to transform addictive behaviors. He has been a DEA-licensed provider for over a decade, treating opioid addiction with buprenorphine maintenance therapy.

Dr. Radowitz sees the source of disease as a “dis-ease” that results from a misalignment of mind, body, and spirit. He has a passion for preventive medicine, getting to the root of a health problem before it manifests. In contrast to traditional medicine, he views psychedelics as powerful tools to help us become aware of the origin of imbalance and guide us toward wholeness, health, and wellbeing, healing from within. He and the Nushama team have administered thousands of ketamine journeys for mood disorders and are known to be best-in-class and among the most experienced globally.

Before joining Nushama, Dr. Radowitz ran the primary care program at Goldman Sachs for over 10 years and held a private practice specializing in general medicine, HIV care, and preventive medicine. He completed his Bachelor of Science in Anatomy and Cell Biology from McGill University and his medical degree at The Chicago Medical School with an internal medicine residency at Rush University Medical Center. He currently mentors master’s students attending the Columbia School of Social Work interning at Nushama for their field practicum and has also supervised Columbia medical students and residents.


Dr. Radowitz's personal journey towards spirituality began after moving to New York from Montreal. He explored the city’s culture and nightlife on a journey to expand his consciousness and eventually discovered the study of Kabbalah, Jewish mysticism, transcendental meditation, and various forms of yoga. After reading How to Change Your Mind, he witnessed the profound transformation that psychedelics can bring and serendipitously met Co-Founder Jay Godfrey, who invited him to join Nushama.

For more information, please visit my practice website: https://drleeds.com and the podcast website: https://therehab.com